PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(1), P. e0244763 - e0244763
Published: Jan. 4, 2021
Background
&
aim
Non-alcoholic
steatohepatitis
(NASH)
is
a
severe
form
of
non-alcoholic
fatty
liver
disease
(NAFLD)
that
responsible
for
growing
fraction
cirrhosis
and
cancer
cases
worldwide.
Changes
in
the
gut
microbiome
have
been
implicated
NASH
pathogenesis,
but
lack
suitable
murine
models
has
barrier
to
progress.
We
therefore
characterized
well-validated
model
establish
its
value
modeling
human
disease.
Methods
The
composition
intestinal
microbiota
was
monitored
mice
on
12-
or
24-week
protocol
consisting
high
fat,
sugar
Western
Diet
(WD)
plus
once
weekly
i.p
injection
low-dose
CCl
4
.
Additional
were
subjected
WD-only
-only
conditions
assess
independent
effect
these
variables
microbiome.
Results
There
substantial
remodeling
mice,
by
declines
both
species
diversity
bacterial
abundance.
Based
changes
beta
diversity,
from
clustered
separately
controls
principal
coordinate
analyses.
A
comparison
between
with
identified
WD
as
primary
driver
early
microbiome,
resulting
loss
within
1
st
week.
signature
emerged
progressively
at
weeks
6
12,
including,
most
notably,
reproducible
bloom
Firmicute
order
Erysipelotrichales
Conclusions
established
valuable
study
role
microbes
NASH,
enabling
us
identify
new
signature.
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 2, 2023
Non-alcoholic
fatty
liver
disease
(NAFLD)
represents
a
severe
public
health
problem.
Dysbiosis
of
gut
microbiome
has
been
identified
as
one
the
key
environmental
factors
contributing
to
NAFLD.
As
an
essential
nutrition,
Vitamin
D
(VD)
plays
important
role
in
regulating
microbiota
based
on
its
receptor
(Vitamin
Receptor,
VDR)
which
is
highly
expressed
gastrointestinal
tract.Rats
were
fed
with
HFD
(high-fat
diet)
for
12
weeks.
And
rats
treated
VD
two
times
week
by
intraperitoneal
injection
H&E
staining
combined
plasma
biochemical
index
was
performed
characterize
pathological
changes
and
function
liver.
Fecal
16S
rRNA
gene
sequencing
metabolomics
taken
reveal
altered
metabolites.The
alleviates
HFD-induced
lipid
accumulation
well
decreases
levels
amlodipine
besylate
(ALT)
aspartate
(AST).
supplement
decreased
ratio
phylum
Firmicutes/Bacteroidetes
(F/B)
but
increased
alpha
diversity.
In
addition,
treatment
improved
increasing
Prevotella
Porphyromonadaceae
decreasing
Mucispirillum,
Acetatifactor,
Desulfovibrio,
Oscillospira
abundance.
Furthermore,
capability
tyrosine
metabolism,
tryptophan
arginine
biosynthesis,
sphingolipid
metabolism
enhanced
after
treatment.
Consistently,
positively
correlated
metabolism.
Importantly,
abundance
associated
serotonin,
melatonin,
tryptamine,
L-arginine,
3-dehydrosphinganine
synthesize
from
tryptophan,
tyrosine,
arginosuccinate,
serine,
respectively.VD
inhibited
NAFLD
accompany
dysbiosis
metabolites,
suggesting
that
could
be
potential
intervention
used
targeting
specific
microbiota.
Hormone and Metabolic Research,
Journal Year:
2024,
Volume and Issue:
56(10), P. 683 - 696
Published: March 12, 2024
Abstract
Obesity,
non-alcoholic
fatty
liver
disease
(NAFLD),
and
atherosclerotic
cardiovascular
diseases
are
common
growing
public
health
concerns.
Previous
epidemiological
studies
unfolded
the
robust
correlation
between
obesity,
NAFLD,
diseases.
Obesity
is
a
well-known
risk
factor
for
both
of
them
can
markedly
increase
odds
On
other
hand,
significant
weight
loss
achieved
by
lifestyle
modification,
bariatric
surgery,
or
medications,
such
as
semaglutide,
concomitantly
improve
NAFLD
Therefore,
certain
pathophysiological
links
involved
in
development
obesity
NAFLD.
Moreover,
recent
indicated
that
simultaneously
targeting
several
mechanisms
tirzepatide
retatrutide
leads
to
greater
improves
complications
metabolic
syndrome.
These
findings
remind
importance
mechanistic
viewpoint
breaking
association
In
this
review
article,
we
mainly
focus
on
shared
mechanisms,
including
insulin
resistance,
dyslipidemia,
GLP1
signaling,
inflammation,
oxidative
stress,
mitochondrial
dysfunction,
gut
dysbiosis,
renin-angiotensin-aldosterone
system
(RAAS)
overactivity,
endothelial
dysfunction.
Most
these
alterations
primarily
initiated
obesity.
The
further
exacerbates
molecular
cellular
alterations,
leading
progression
final
manifestation
perturbation.
A
better
insight
into
makes
it
feasible
develop
new
multi-target
approaches
unhinge
deleterious
chain
events
linking
Abstract
The
gut
microbiota
is
a
complex
community
of
microorganisms
inhabiting
the
intestinal
tract,
which
plays
vital
role
in
human
health.
It
intricately
involved
metabolism,
and
it
also
affects
diverse
physiological
processes.
gut–lung
axis
bidirectional
pathway
between
gastrointestinal
tract
lungs.
Recent
research
has
shown
that
microbiome
crucial
immune
response
regulation
lungs
development
lung
diseases.
In
this
review,
we
present
interrelated
factors
concerning
associated
metabolites
pulmonary
hypertension
(PH),
lethal
disease
characterized
by
elevated
vascular
pressure
resistance.
Our
team
explored
gut‐microbiota‐derived
cardiovascular
diseases
established
correlation
such
as
putrescine,
succinate,
trimethylamine
N‐oxide
(TMAO),
N,
N‐trimethyl‐5‐aminovaleric
acid
with
Furthermore,
found
specific
metabolites,
TMAO
betaine,
have
significant
clinical
value
PH,
suggesting
their
potential
biomarkers
management.
detailing
interplay
microbiota,
underscored
therapeutic
approaches
modulating
microbiota.
Ultimately,
endeavor
to
alleviate
substantial
socioeconomic
burden
disease.
This
review
presents
unique
exploratory
analysis
link
intending
propel
further
investigations
axis.
PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(1), P. e0244763 - e0244763
Published: Jan. 4, 2021
Background
&
aim
Non-alcoholic
steatohepatitis
(NASH)
is
a
severe
form
of
non-alcoholic
fatty
liver
disease
(NAFLD)
that
responsible
for
growing
fraction
cirrhosis
and
cancer
cases
worldwide.
Changes
in
the
gut
microbiome
have
been
implicated
NASH
pathogenesis,
but
lack
suitable
murine
models
has
barrier
to
progress.
We
therefore
characterized
well-validated
model
establish
its
value
modeling
human
disease.
Methods
The
composition
intestinal
microbiota
was
monitored
mice
on
12-
or
24-week
protocol
consisting
high
fat,
sugar
Western
Diet
(WD)
plus
once
weekly
i.p
injection
low-dose
CCl
4
.
Additional
were
subjected
WD-only
-only
conditions
assess
independent
effect
these
variables
microbiome.
Results
There
substantial
remodeling
mice,
by
declines
both
species
diversity
bacterial
abundance.
Based
changes
beta
diversity,
from
clustered
separately
controls
principal
coordinate
analyses.
A
comparison
between
with
identified
WD
as
primary
driver
early
microbiome,
resulting
loss
within
1
st
week.
signature
emerged
progressively
at
weeks
6
12,
including,
most
notably,
reproducible
bloom
Firmicute
order
Erysipelotrichales
Conclusions
established
valuable
study
role
microbes
NASH,
enabling
us
identify
new
signature.